Baseline risk factors and their association with outcome in the West of Scotland Coronary Prevention Study

American Journal of Cardiology

Volumn 79, Issue 6, 1997, Pages 756-762

  Cobbe, Stuart M ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; NITRIC ACID DERIVATIVE; PLACEBO; PRAVASTATIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FAMILY HISTORY; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; RISK FACTOR; TREATMENT OUTCOME; UNITED KINGDOM;

ANTICHOLESTEREMIC AGENTS; CORONARY DISEASE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PRAVASTATIN; PROBABILITY; RISK FACTORS; SCOTLAND; TIME FACTORS; TREATMENT OUTCOME;

EID: 0343990784     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00863-6     Document Type: Article

References (32)

1. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, Mckillop JH, Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 333:1995;1301-1307.
2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 344:1994;1383-1389.
3. Davey Smith G, Pekkanen J. Should there be a moratorium on the use of cholesterol lowering drugs. Br Med J. 304:1992;431-434.
4. Oliver MF. Might treatment of hypercholesterolemia increase non-cardiac mortality. Lancet. 337:1991;1529-1531.
5. Hulley SB, Walsh JMB, Newman TB. Editorial. Health policy on blood cholesterol: time to change directions. Circulation. 86:1992;1026-1029.
6. Gotto AM Jr, LaRosa JC, Hunninghake D, Grundy SM, Wilson PW, Clarkson TB, Hay JW, Goodman DS. The cholesterol facts: a summary of the evidence relating dietary fats, serum cholesterol and coronary heart disease. Circulation. 81:1990;1721-1733.
7. Second report of the expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Circulation. 89:1994;1329-1445.
8. Anderson KM, Odell PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 121:1991;293-298.
9. Assmann G, Schulte H. Relation of high density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol. 70:1992;733-737.
10. Shaper AG, Pocock SJ, Phillips AN, Walker M. Identifying men at high risk of heart attacks: strategy for use in general practice. Br Med J. 293:1986;474-479.
11. A coronary primary prevention study of Scottish men aged 45-64: trial design. J Clin Epidemiol. 45:1992;849-860.
12. Screening experience and baseline characteristics in the West of Scotland Coronary Prevention Study. Am J Cardiol. 76:1995;485-491.
13. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular Survey Methods. 2nd ed. 1982;World Health Organization, Geneva.
14. Lipid Research Clinics Mannual of Laboratory Operations, 1975. Government Printing Office, Washington DC, DHEW Publication Number NIH85-268.
15. Kendrick S, Clarke J. The Scottish record linkage system. Health Bull. 51:1993;72-79.
16. Computerised record linkage: compared with traditional follow-up methods in clinical trials and illustrated in a prospective epidemiological study. J Clin Epidemiol. 48:1996;1441-1452.
17. Collett D. Modelling Survival Data in Medical Research. 1994;Chapman and Hall, London.
18. Baseline serum cholesterol and treatment effect in the Scandanavian Simvastatin Survival Study (4S). Lancet. 345:1995;1274-1275.
19. Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb. 11:1991;2-14.
20. Castelli WP. The triglyceride issue: a view from Framingham. Am Heart J. 112:1986;432-437.
21. Grundy SM. Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Arch Intern Med. 152:1992;28-34.
22. Shaper AG, Pocock SJ, Walker M, Phillips AN, Whitehead TP, Macfarlane PW. Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Commun Health. 39:1985;197-209.
23. Kannel WB, Anderson K, McGee D, Degatano LS, Stampfer MJ. Nonspecific electrocardiographic abnormality as a predictor of coronary heart disease: the Framingham Study. Am Heart J. 113:1987;370-376.
24. Wannamethee G, Shaper AG, Macfarlane PW, Walker M. Risk factors for sudden cardiac death in middle aged British men. Circulation. 91:1995;1749-1756.
25. Watt GCM, Hart CL, Hole DJ, Smith GD, Gillis CR, Hawthorne VM. Risk factors for cardiorespiratory and all cause mortality in men and women in urban Scotland: 15 year follow up. Scott Med J. 40:1995;108-112.
26. Goldsmith JR. What do we expect from an occupational cohort. J Occup Med. 17:1975;126-127.
27. Chandra V, Szklo M, Goldberg R, Tonascia J. The impact of marital status on survival after an acute myocardial infarction: a population-based survey. Am J Epidemiol. 117:1983;320-325.
28. Findlay IN, Dargie HJ, Dyke T. Coronary angiography in Glasgow: relation to coronary heart disease and social class (abstr). Br Heart J. 66:1991;70.
29. Morris RW, McCallum AK, Walker M, Whincup PM, Ebrahim S, Shaper AG. Cigarette smoking in British men and selection for coronary artery bypass surgery. Heart. 75:1996;557-562.
30. Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. Ann Intern Med. 124:1996;515-517.
31. Garber AM, Browner WS, Hulley SB. Cholesterol screening in asymptomatic adults, revisited. Ann Intern Med. 124:1996;518-531.
32. LaRosa JC. Cholesterol agonistics. Ann Intern Med. 124:1996;505-508.